Vyome Co-Founder Dr. Shiladitya Sengupta Promoted to Professor at Harvard Medical School

Shiladitya Sengupta, Co-Founder and Director of Vyome

“I am deeply honored by this academic recognition. My scientific journey has been driven by a simple question: how can our understanding of biology and disease mechanisms be translated into better therapeutic approaches for patients? Over the years, I have had the opportunity to work with exceptional scientists, clinicians, and students across several disciplines. This appointment is a recognition of that collective scientific journey and the contributions of the many people I have worked with. Co-founding Vyome has been an important part of my efforts to connect fundamental research with patient care. I continue to believe that the greatest opportunities in biotechnology lie at the intersection of strong science, interdisciplinary thinking and a deep understanding of unmet medical needs.”

Venkat Nelabhotla, CEO of Vyome

“Dr. Sengupta’s promotion to Professor at Harvard Medical School is a wonderful recognition of his many years of scientific work and his contributions to translational medicine. I have had the privilege of working closely with him in building Vyome, and what has always impressed me is his ability to connect fundamental science with real problems that patients face. Building an innovative biotechnology company requires much more than good science. This recognition is a matter of great pride for all of us at Vyome. It also reinforces our belief that experienced scientific leadership, combined with disciplined development and execution, is fundamental to building a globally competitive biotechnology company.”